sPLA2-III deletion decreased the total tumor burden in the colon after AOM treatment, the number of large (>2 mm in diameter) and small (<2 mm) tumors being markedly lower in Pla2g3−/− mice than in Pla2g3+/+ mice (Fig. 2b,c). This evidence concerns the gene PLA2G3 and neoplasm.